Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

ASX/CHM stock hub

ASX/CHM has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

ASX/CHMis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

Australian Securities Exchange

Market data

Live price

Current market quote for this ticker.

Current price

ASX/CHM

In the news

Latest news · ASX/CHM

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.9P50 20.4P75 41.2

Trailing P/En/a

P25 14.2P50 19.2P75 35.1

ROE-1,291

P25 -118.7P50 -49.4P75 -1.2

ROIC-228

P25 -74.7P50 -33.5P75 0.1

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All ASX/CHM market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

163

Groups with data

Currency

AUD

Showing 163 of 163 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Australia
Country code	AU
Enterprise value	AUD 4.5M
Exchange	Australian Securities Exchange
Financial currency	AUD
First seen	2026-05-10
Industry	Biotechnology
Isin	AU0000121576
Last refreshed	2026-05-10
Market cap	AUD 7M
Price	AUD 0.14
Price currency	AUD
Sector	Healthcare
Sic	2836
Symbol	asx/CHM
Website	https://www.chimerictherapeutics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-268.56%
EV Earnings	-0.24x
EV/Sales	0.46x
P/B ratio	-2.31x
P/S ratio	0.72x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-54.44%
EBITDA Margin	-43.86%
Gross margin	91.32%
Gross Profit	AUD 8.9M
Gross Profit Growth	-24.79%
Gross Profit Growth Q	-52.84%
Gross Profit Growth3 Y	6.08%
Gross Profit Growth5 Y	14.59%
Net Income	AUD -18.8M
Net Income Growth Years	2%
Pretax Margin	-192.54%
Profit Margin	-192.71%
ROA	-26.96
Roa5y	-38.75
ROCE	365.2
ROE	-1,291
Roe5y	-225.2
ROIC	-228

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-73.02%
Cagr3y	-71.14%
Cagr5y	-64.2%
EPS Growth Years	2
Revenue Growth	377.63x
Revenue Growth Q	-52.84x
Revenue Growth Years	0x
Revenue Growth3 Y	9.34x
Revenue Growth5 Y	16.69x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	AUD 0.79
Assets	AUD 5.9M
Cash	AUD 2.5M
Current Assets	AUD 5.1M
Current Liabilities	AUD 7.4M
Equity	AUD -3M
Interest Coverage	-17.5
Liabilities	AUD 9M
Long Term Assets	AUD 804,891
Long Term Liabilities	AUD 1.6M
Net Cash	AUD 2.5M
Net Cash By Market Cap	AUD 35.79
Net Cash Growth	-50.6%
Tangible Book Value	AUD -3.8M
Tangible Book Value Per Share	AUD -0.09
WACC	8.99

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.69
Net Working Capital	AUD -4.8M
Quick ratio	0.68
Working Capital	AUD -2.3M
Working Capital Turnover	AUD -3.66

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-169.62%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-73%
200-day SMA	0.28
3Y total return	-97.6%
50-day SMA	0.18
50-day SMA vs 200-day SMA	50under200
5Y total return	-99.41%
All Time High	44
All Time High Change	-99.69%
All Time High Date	2021-01-21
All Time Low	0.1
All Time Low Change	35%
All Time Low Date	2026-02-27
ATR	0.04
Beta	0.86
Beta1y	-1.49
Beta2y	-0.24
Ch YTD	-32.5
High	0.15
High52	0.9
High52 Date	2025-05-15
High52ch	-85%
Low	0.14
Low52	0.1
Low52 Date	2026-04-21
Low52ch	35%
Ma50ch	-25.62%
Price vs 200-day SMA	-51.1%
RSI	43.03
RSI Monthly	22.98
RSI Weekly	37.02
Sharpe ratio	0.95x
Sortino ratio	1.79
Total Return	-169.62%
Tr YTD	-32.5
Tr1m	-32.5%
Tr1w	-18.18%
Tr3m	-46%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	AUD -5.3M
Operating margin	-54.44

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	32,594,013%
Net Borrowing	-4,102,610
Shares Insiders	35.27%
Shares Institutions	4.69%
Shares Out	51,822,282
Shares Qo Q	91.81%
Shares Yo Y	169.62%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	89,508.15x
Bv Per Share	-0.07
Ch1m	-32.5
Ch1w	-18.18
Ch1y	-73
Ch3m	-46
Ch3y	-97.71
Ch5y	-99.46
Ch6m	-55
Change	-6.9%
Change From Open	-6.9
Close	0.15
Days Gap	0
Depreciation Amortization	1,032,057
Dollar Volume	40,826.2
Earnings Date	2026-05-28
EBIT	AUD -5.3M
EBITDA	AUD -4.3M
EPS	AUD -0.76
F Score	2
Financing CF	6,284,747
Fiscal Year End	June
Founded	2,020
Income Tax	AUD 16,158
Investing CF	-242,338
Is Primary Listing	1
Last Earnings Date	2026-02-27
Last Report Date	2025-12-31
Last Split Date	2026-04-22
Last Split Type	Reverse
Ma150	0.25
Ma150ch	-45.96%
Ma20	0.17
Ma20ch	-22.32%
Net CF	-2,564,392
Next Earnings Date	2026-05-28
Open	0.15
Position In Range	0
Price Date	2026-05-08
Relative Volume	3.92x
Revenue	9,749,833x
SBC By Revenue	11.14x
Share Based Comp	1,086,254
Tax By Revenue	0.17x
Tr6m	-55%
Volume	302,416
Z Score	-21.77

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does ASX/CHM pay a dividend?

Capital-return profile for this ticker.

Performance

ASX/CHM stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns ASX/CHM?

Insider, institutional, and short-interest positioning.

Institutional ownership

+4.7%

Share of float held by funds and institutions

Insider ownership

+35.3%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+169.6%

Negative means the company is buying back shares.

Technical

ASX/CHM momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

43.0

Neutral momentum band

Price vs 200-day MA

-51.1%

50/200-day relationship not available

Beta (5Y)

0.86

Moves roughly with the market

Sharpe ratio

0.95

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About ASX/CHM

Hub-level FAQ points readers to the deeper analysis pages.

What is the current asx/CHM stock rating?

asx/CHM is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full asx/CHM analysis?

The full report lives at /stocks/asx/CHM/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for asx/CHM?

The latest report frames asx/CHM around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the asx/CHM page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.